COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC
MedImmune LLC
MedImmune LLC
Intima Bioscience, Inc.
A2 Biotherapeutics Inc.
Arvinas Inc.
GlaxoSmithKline
Shanghai Henlius Biotech
Eli Lilly and Company
Takeda
NantCell, Inc.
Revolution Medicines, Inc.
Eli Lilly and Company
Mirati Therapeutics Inc.
A2 Biotherapeutics Inc.
Palleon Pharmaceuticals, Inc.
Turning Point Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Hoffmann-La Roche
Intensity Therapeutics, Inc.
PureTech
NextCure, Inc.
Coherent Biopharma (Hefei) Co., Ltd.
Chongqing Precision Biotech Co., Ltd
NantBioScience, Inc.
NantCell, Inc.
NextCure, Inc.
Gilead Sciences
Klus Pharma Inc.
Kineta Inc.
Eisai Inc.
Chongqing Precision Biotech Co., Ltd
Faron Pharmaceuticals Ltd
Gilead Sciences
Gilead Sciences
Sabz Biomedicals
SillaJen, Inc.
Isofol Medical AB
Petra Pharma
Surgimab
Celleron Therapeutics Ltd.
Generic Devices Consulting, Inc.
Leaf Vertical Inc.
MediGene
Precision Biologics, Inc
Amgen
Amgen
Photocure
AlphaVax, Inc.
Stryker GI Ltd.
ARCA Biopharma, Inc.